[1]
Al-Shammari, A.H. et al. 2023. Effect of intralesional levofloxacin in the treatment of cutaneous leishmaniasis: intralesional levofloxacin for cutaneous leishmaniasis treatment. Journal of Population Therapeutics and Clinical Pharmacology. 30, 1 (Feb. 2023). DOI:https://doi.org/10.47750/jptcp.2023.1028.